1. Home
  2. PMCB vs DLPN Comparison

PMCB vs DLPN Comparison

Compare PMCB & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • DLPN
  • Stock Information
  • Founded
  • PMCB 1996
  • DLPN N/A
  • Country
  • PMCB United States
  • DLPN United States
  • Employees
  • PMCB 2
  • DLPN N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • DLPN Other Consumer Services
  • Sector
  • PMCB Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • PMCB Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • PMCB 11.4M
  • DLPN 12.9M
  • IPO Year
  • PMCB N/A
  • DLPN N/A
  • Fundamental
  • Price
  • PMCB $1.64
  • DLPN $1.07
  • Analyst Decision
  • PMCB
  • DLPN Strong Buy
  • Analyst Count
  • PMCB 0
  • DLPN 1
  • Target Price
  • PMCB N/A
  • DLPN $5.00
  • AVG Volume (30 Days)
  • PMCB 14.0K
  • DLPN 42.6K
  • Earning Date
  • PMCB 12-24-2024
  • DLPN 11-14-2024
  • Dividend Yield
  • PMCB N/A
  • DLPN N/A
  • EPS Growth
  • PMCB N/A
  • DLPN N/A
  • EPS
  • PMCB 0.74
  • DLPN N/A
  • Revenue
  • PMCB N/A
  • DLPN $51,389,626.00
  • Revenue This Year
  • PMCB N/A
  • DLPN $21.74
  • Revenue Next Year
  • PMCB N/A
  • DLPN $7.26
  • P/E Ratio
  • PMCB $2.21
  • DLPN N/A
  • Revenue Growth
  • PMCB N/A
  • DLPN 21.66
  • 52 Week Low
  • PMCB $1.39
  • DLPN $0.95
  • 52 Week High
  • PMCB $2.58
  • DLPN $3.58
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 45.24
  • DLPN 42.93
  • Support Level
  • PMCB $1.60
  • DLPN $1.02
  • Resistance Level
  • PMCB $1.69
  • DLPN $1.15
  • Average True Range (ATR)
  • PMCB 0.11
  • DLPN 0.09
  • MACD
  • PMCB -0.00
  • DLPN -0.01
  • Stochastic Oscillator
  • PMCB 40.00
  • DLPN 17.14

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: